HomeLYRA • NASDAQ
add
Lyra Therapeutics Inc
Previous close
$25.33
Day range
$22.22 - $27.42
Year range
$3.81 - $37.50
Market cap
32.18M USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 183.00K | -65.60% |
Operating expense | 3.26M | -43.92% |
Net income | -8.55M | 61.93% |
Net profit margin | -4.67K | -10.67% |
Earnings per share | — | — |
EBITDA | -7.83M | 66.53% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.74M | -63.57% |
Total assets | 56.32M | -60.21% |
Total liabilities | 52.44M | -18.09% |
Total equity | 3.87M | — |
Shares outstanding | 1.33M | — |
Price to book | 8.62 | — |
Return on assets | -32.43% | — |
Return on capital | -47.81% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.55M | 61.93% |
Cash from operations | -8.84M | 60.62% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -8.84M | -48.51% |
Free cash flow | -5.02M | 65.94% |
About
Founded
2005
Headquarters
Website
Employees
30
